Abstract

Alzheimer disease (AD) is a major cause of age-related dementia. We do not fully understand AD aetiology and pathogenesis, but oxidative damage is a key component. The brain mostly uses glucose for energy, but in AD and amnestic mild cognitive impairment glucose metabolism is dramatically decreased, probably owing, at least in part, to oxidative damage to enzymes involved in glycolysis, the tricarboxylic acid cycle and ATP biosynthesis. Consequently, ATP-requiring processes for cognitive function are impaired, and synaptic dysfunction and neuronal death result, with ensuing thinning of key brain areas. We summarize current research on the interplay and sequence of these processes and suggest potential pharmacological interventions to retard AD progression.

Keywords

Oxidative stressDementiaGlycolysisOxidative phosphorylationDiseaseCitric acid cycleNeurodegenerationNeuroscienceAlzheimer's diseaseCarbohydrate metabolismPathogenesisBiologyBrain damageMedicineMetabolismBiochemistryInternal medicine

MeSH Terms

Alzheimer DiseaseAnimalsBrainDisease ProgressionGlucose IntoleranceGlycolysisHumansOxidative Stress

Affiliated Institutions

Related Publications

Publication Info

Year
2019
Type
review
Volume
20
Issue
3
Pages
148-160
Citations
1685
Access
Closed

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

1685
OpenAlex
36
Influential

Cite This

D. Allan Butterfield, Barry Halliwell (2019). Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease. Nature reviews. Neuroscience , 20 (3) , 148-160. https://doi.org/10.1038/s41583-019-0132-6

Identifiers

DOI
10.1038/s41583-019-0132-6
PMID
30737462
PMCID
PMC9382875

Data Quality

Data completeness: 90%